CAS
RMD icon

CTC Alternative Strategies’s ResMed RMD Stock Holding History

CTC Alternative Strategies’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,100
Closed -$575K – 88
2025
Q3 		$575K Buy
+2,100
New +$574K 0.93% 30
2024
Q3 		– Sell
-4,386
Closed -$840K – 176
2024
Q2 		$840K Buy
+4,386
New +$890K 0.36% 71

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

CTC Alternative Strategies's RMD Position: Q4 2025 in Review

CTC Alternative Strategies sold out of ResMed (RMD) in Q4 2025, closing a stake of 2,100 shares — an estimated $575K sold.

CTC Alternative Strategies first reported a position in RMD in Q2 2024 and held it in 2 quarters. The position peaked at $840K in Q2 2024. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • CTC Alternative Strategies reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • CTC Alternative Strategies sold 2,100 ResMed shares in Q4 2025, an estimated $575K.
  • CTC Alternative Strategies first reported a position in ResMed in Q2 2024 and held it in 2 quarters.
  • CTC Alternative Strategies's ResMed position peaked at $840K in Q2 2024.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on CTC Alternative Strategies's 13F filing for Q4 2025, filed 18 Feb 2026.